Cardinals will be back … and often


It’s going to be a somber plane ride back to St. Louis for the Cardinals following Wednesday night’s World Series ouster at Fenway Park, but these birds will be playing on big stages for years and years to come.

There may not be a team in baseball that is better-poised for an extended run of future success.

Adam Wainwright is an established ace and under contract through 2018. Michael Wacha has all the tools to join Wainwright in that elite category, and Shelby Miller would have been a National League Rookie of the Year shoe-in if not for Marlins young stud Jose Fernandez. Carlos Martinez could join Wainwright, Wacha and Miller in the St. Louis starting rotation in 2014 and Joe Kelly, Lance Lynn and Jaime Garcia are just a few of the organization’s other starting pitching options. Trevor Rosenthal — the club’s current fireballing young closer — has said publicly that he wants an opportunity to be a starter.

And that’s just the rotation. Kevin Siegrist, a 24-year-old lefty, is a rising star in the Cardinals’ bullpen. Seth Maness, a 25-year-old righty, posted a 2.32 ERA over his first 62 major league innings this season. John Axford, who found new life after arriving in St. Louis via a waiver trade, is eligible for salary arbitration. Jason Motte should be recovered from his Tommy John reconstructive elbow surgery around early May.

Matt Holliday is locked in through at least 2016, Yadier Molina is locked in through at least 2017 and Allen Craig signed a big extension this past spring that can keep him in St. Louis through 2018. Matt Carpenter emerged as an MVP candidate this summer and top outfield prospect Oscar Taveras is ready to step in for Carlos Beltran, who is all but certain to accept a multi-year contract elsewhere in free agency. Exciting second base prospect Kolten Wong has the look of a future major league regular and could claim a starting job as early as 2014 if the Cardinals move Carpenter to third base and part ways with the arbitration-eligible David Freese. Don’t forget imposing slugger Matt Adams, who flashed game-changing power this year.

The Cardinals are stacked with good, young talent and have more than $30 million in player salaries coming off the books this winter between Beltran, Rafael Furcal, Chris Carpenter and Jake Westbrook.

The only real hole is at shortstop — and maybe center field — and the Cardinals will have the budget to make a major upgrade there. The most-storied franchise in the National League will write many more chapters.

Jorge Polanco suspended 80 games after testing positive for Stanozolol

Brian Blanco/Getty Images
Leave a comment’s Rhett Bollinger reports that Twins shortstop Jorge Polanco has been suspended 80 games after testing positive for the performance-enhancing drug Stanozolol.

In a statement, via Dan Hayes of The Athletic, Polanco denied knowingly using the substance. Polanco said, “To be clear, I did not intentionally consume this steroid. I now know, however, that my intention alone is not a good enough excuse and I will pay the price for my error in judgment. The substance that I requested from my athletic trainer in the Dominican Republic and consented to take was a combination of vitamin B12 and an iron supplement, something that is not unusual or illegal for professional athletes to take. Unfortunately, what I was given was not that supplement and I take full responsibility for what is in my body.”

Last year was Polanco’s first full season in the majors. He hit .256/.313/.410 with 13 home runs, 74 RBI, 60 runs scored, and 13 stolen bases in 544 plate appearances.

The Twins have Ehire Adrianza and Erick Aybar to handle shortstop while Polanco is out. The club could also give the starting job to prospect Nick Gordon, ranked No. 4 in the Twins’ system according to MLB Pipeline. Gordon had a solid 2017 campaign at Double-A Chattanooga, posting a .749 OPS with 29 doubles and 13 steals in 578 PA.